Ebola Uveitis

Aaron Lindeke-Myers; Steven Yeh; Jessica G. Shantha

doi:10.1016/B978-0-323-69541-1.00071-9

Ebola Uveitis

Aaron Lindeke-Myers, Steven Yeh, Jessica G. Shantha

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The West African Ebola virus disease (EVD) is found primarily within Liberia, Guinea, and Sierra Leone. EVD is an acute, viral hemorrhagic fever characterized by severe fevers, diarrhea, vomiting, dehydration, and a high case fatality rate. After recovery from acute EVD, survivors are at high risk of uveitis, among other systemic sequelae. The prevalence of uveitis has been estimated between 25% and 33%. The patient described is a Liberian patient who survived EVD and subsequently developed bilateral, asynchronous panuveitis after discharge from the Ebola treatment unit. Her ocular complications included corneal edema, keratic precipitates, posterior synechiae, and vitreous opacity, leading to bilateral, severe vision loss. Her clinical course and management are summarized.

Original language	English (US)
Title of host publication	Clinical Cases in Uveitis
Subtitle of host publication	Differential Diagnosis and Management
Publisher	Elsevier
Pages	74-76
Number of pages	3
ISBN (Electronic)	9780323695411
DOIs	https://doi.org/10.1016/B978-0-323-69541-1.00071-9
State	Published - Jan 1 2021
Externally published	Yes

Keywords

Ebola virus disease
Panuveitis
Posterior synechiae
Viral hemorrhagic fever
West Africa

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/B978-0-323-69541-1.00071-9

Cite this

@inbook{d7c9ec3f9c104a4bbc18124b21e2f60f,

title = "Ebola Uveitis",

abstract = "The West African Ebola virus disease (EVD) is found primarily within Liberia, Guinea, and Sierra Leone. EVD is an acute, viral hemorrhagic fever characterized by severe fevers, diarrhea, vomiting, dehydration, and a high case fatality rate. After recovery from acute EVD, survivors are at high risk of uveitis, among other systemic sequelae. The prevalence of uveitis has been estimated between 25% and 33%. The patient described is a Liberian patient who survived EVD and subsequently developed bilateral, asynchronous panuveitis after discharge from the Ebola treatment unit. Her ocular complications included corneal edema, keratic precipitates, posterior synechiae, and vitreous opacity, leading to bilateral, severe vision loss. Her clinical course and management are summarized.",

keywords = "Ebola virus disease, Panuveitis, Posterior synechiae, Viral hemorrhagic fever, West Africa",

author = "Aaron Lindeke-Myers and Steven Yeh and Shantha, {Jessica G.}",

year = "2021",

month = jan,

day = "1",

doi = "10.1016/B978-0-323-69541-1.00071-9",

language = "English (US)",

pages = "74--76",

booktitle = "Clinical Cases in Uveitis",

publisher = "Elsevier",

}

TY - CHAP

T1 - Ebola Uveitis

AU - Lindeke-Myers, Aaron

AU - Yeh, Steven

AU - Shantha, Jessica G.

PY - 2021/1/1

Y1 - 2021/1/1

N2 - The West African Ebola virus disease (EVD) is found primarily within Liberia, Guinea, and Sierra Leone. EVD is an acute, viral hemorrhagic fever characterized by severe fevers, diarrhea, vomiting, dehydration, and a high case fatality rate. After recovery from acute EVD, survivors are at high risk of uveitis, among other systemic sequelae. The prevalence of uveitis has been estimated between 25% and 33%. The patient described is a Liberian patient who survived EVD and subsequently developed bilateral, asynchronous panuveitis after discharge from the Ebola treatment unit. Her ocular complications included corneal edema, keratic precipitates, posterior synechiae, and vitreous opacity, leading to bilateral, severe vision loss. Her clinical course and management are summarized.

AB - The West African Ebola virus disease (EVD) is found primarily within Liberia, Guinea, and Sierra Leone. EVD is an acute, viral hemorrhagic fever characterized by severe fevers, diarrhea, vomiting, dehydration, and a high case fatality rate. After recovery from acute EVD, survivors are at high risk of uveitis, among other systemic sequelae. The prevalence of uveitis has been estimated between 25% and 33%. The patient described is a Liberian patient who survived EVD and subsequently developed bilateral, asynchronous panuveitis after discharge from the Ebola treatment unit. Her ocular complications included corneal edema, keratic precipitates, posterior synechiae, and vitreous opacity, leading to bilateral, severe vision loss. Her clinical course and management are summarized.

KW - Ebola virus disease

KW - Panuveitis

KW - Posterior synechiae

KW - Viral hemorrhagic fever

KW - West Africa

UR - http://www.scopus.com/inward/record.url?scp=85159035274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85159035274&partnerID=8YFLogxK

U2 - 10.1016/B978-0-323-69541-1.00071-9

DO - 10.1016/B978-0-323-69541-1.00071-9

M3 - Chapter

AN - SCOPUS:85159035274

SP - 74

EP - 76

BT - Clinical Cases in Uveitis

PB - Elsevier

ER -

Ebola Uveitis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this